The safety of the use of the conditioned medium obtained by directed osteogenic induction of rat bone marrow mesenchymal stem cells

Author: Pokrovskaya L.A.¹, Sherstoboev E.Yu.², Nadezhdin S.V.³, Danilets M.G.⁴, Trofimova E.S.⁵, Ligacheva A.A.⁶, Churin A.A.⁷, Dubskaya T.Yu.⁸

Author Affiliations

Abstract

The purpose of the study was to evaluate in vitro cytotoxicity and in vivo sub-acute toxicity of conditioned medium obtained from rat bone marrow-derived mesenchymal stem cells directed to osteogenic differentiation. Material and methods. Conditioned medium was obtained by culturing rat bone marrow-derived MSCs induced under osteogenic condition. Results and discussion. Conditioned medium from rat bone marrow-derived MSCs was shown to have no significant cytotoxic effect on Ehrlich adenocarcinoma cell culture and in vitro expanded peripheral blood mononuclear cells from healthy donors. The use of MSC-CM did not have a significant effect on the state of experimental SD rats, the total body weight and growth rate of animals. A pathomorphologic study revealed no any abnormalities associated with MSC-CM injection. Conclusion. The use of conditioned medium from rat bone marrow-derived mesenchymal stem cells stimulated under osteogenic condition was found to be safe for both in vitro studies (with respect to Ehrlich adenocarcinoma cell line and peripheral blood mononuclear cells from healthy donors) and in vivo studies (injection of MSC-CM to animals).

Key words

rat bone marrow mesenchymal stem cells, conditioned medium, cytotoxicity, subacute toxicity, SD rats

References

Athanasiou V.T., Papachristou D.J., Panagopoulos A., Saridis A., Scopa C.D., Megas P. Histological comparison of autograft, allograft-DBM, xenograft, and synthetic grafts in a trabecular bone defect: an experimental study in rabbits. Med. Sci. Monit. 2010; 16: 24-31.
Cantinieaux D., Quertainmont R., Blacher S., Rossi L., Wanet T., Noël A., Brook G., Schoenen J., Franzen R. Conditioned medium from bone marrow derived mesenchymal stem cells improves recovery after spinal cord injury in rats: an original strategy to avoid cell transplantation. PLoS One. 2013; 8: e69515, doi: 10.1371/journal.pone.0069515
Dawson J.I., Oreffo R.O. Bridging the regeneration gap: stem cells, biomaterials and clinical translation in bone tissue engineering. Arch. Biochem. Biophys. 2008; 473: 124-131. doi: 10.1016/j.abb.2008.03.024
Eppley B.L., Morales L., Wood R., Pensler J., Goldstein J., Havlik R.J., Habal M., Losken A., Williams J.K., Burstein F., Rozzelle A.A., Sadove A.M. Resorbable PLLA-PGA plate and screw fixation in pediatric craniofacial surgery: clinical experience in 1883 patients. Plast. Reconstr. Surg. 2004; 114: 850-856. doi: 10.1097/01.prs.0000132856.69391.43
Eppley B.L., Pietzak W.S., Blanton M.W. Allograft and alloplastic bone substitutes: a review of science and tеchnology for the craniomaxillofacial surgeon. J. Craniofac. Surg. 2005; 16: 981-989. doi: 10.1097/01.scs.0000179662.38172.dd
Grayson W.L., Frohlich M., Yeager K., Bhumiratana S., Chan M.E., Cannizzaro C., Wan L.Q., Liu X.S., Guo X.E., Vunjak-Novakovic G. Engineering anatomically shaped human bone grafts. Proc. Natl. Acad. Sci. USA. 2010; 107: 3299-3304. doi: 10.1073/pnas.0905439106
Han Y., Li X., Zhang Y., Han Y., Chang F., Ding J. Mesenchymal stem cells for regenerative medicine. Cells. 2019; 13; 8(8). doi: 10.1007/5584_2018_213
Horie M., Choi H., Lee R.H., Reger R.L., Ylostalo J., Muneta T., Sekiya I., Prockop D.J. Intra-articular injection of human mesenchymal stem cells (MSCs) promote rat meniscal regeneration by being activated to express Indian hedgehog that enhances expression of type II collagen. Osteoarthritis Cartilage. 2012; 20: 1197-1207. doi: 10.1016/j.joca.2012.06.002
Ide C., Nakai Y., Nakano N., Seo T.B., Yamada Y., Endo K., Noda T., Saito F., Suzuki Y., Fukushima M., Nakatani T. Bone marrow stromal cell transplantation for treatment of sub-acute spinal cord injury in rat. Brain Res. 2010; 1332: 32-47. doi: 10.1016/j.brainres.2010.03.043
Kay A.G., Long G., Tyler G., Stefan A., Broadfoot S.J., Piccinini A.M., Middleton J., Kehoe O. Mesenchymal stem cell-conditioned medium reduces disease severity and immune responses in inflammatory arthritis. Sci. Rep. 2017; 7: e18019. doi: 10.1038/s41598-017-18144-w
Kinnaird T., Srabile E., Burnett M.S., Shou M., Lee C.W., Barr S., Fuchs S., Epstein S.E. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation. 2004; 109: 1543-1549. doi: 10.1161/01.CIR.0000124062.31102.57
Linero I., Chaparro O. Paracrine effect of mesenchymal stem cells derived from human adipose tissue in bone regeneration. PLoS One. 2014; 10: e107001, doi: 10.1371/journal.pone.0107001
Minenna L., Herrero F., Sanz M., Trombelli L. Adjunctive effect of a polylactide/polyglycolide copolymer in the treatment of deep periodontal intra-osseous defects: a randomized clinical trial. J. Clin. Periodontol. 2005; 32: 456-461. doi: 10.1111/j.1600-051X.2005.00696.x
Patel D.M., Shah J., Srivastava A.S. Therapeutic potential of mesenchymal stem cells in regenerative medicine. Stem Cells Int. 2013; 2013: 496218. doi: 10.1155/2013/496218
Pawitan J.A. Prospect of stem cell conditioned medium in regenerative medicine. BioMed. Res. Int. 2014; 2014: 1-14. doi: 10.1155/2014/965849
Perez J.R., Kouroupis D., Li D.J., Best T.M., Kaplan L., Correa D. Tissue Engineering and Cell-Based Therapies for Fractures and Bone Defects. Front. Bioeng. Biotechnol. 2018; 6: 105. doi: 10.3389/fbioe.2018.00105
Perri B., Cooper M., Lauryssen C., Anand N. Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: a case study. Spine J. 2007; 7: 235-239. doi: 10.1016/j.spinee.2006.04.010
Peter S.J., Liang C.R., Kim D.J., Widmer M.S., Mikos A.G. Osteoblastic phenotype of rat marrow stromal cells cultured in the presence of dexamethasone, beta-glycerolphosphate, and L-ascorbic acid. J. Cell Biochem. 1998; 71: 55-62. doi: 10.1002/(sici)1097-4644(19981001)71:1<55::aid-jcb6>3.0.co;2-0
Pittenger M.F., Mbalaviele G., Black M., Mosca J.D., Marshak D.R. Mesenchymal Stem Cells. In: Human cell culture. Eds. M.R. Koller, B.O. Palsson, J.R.W. Masters. Dordrecht: Springer, 2001. Vol. 5: 189-207. doi: 10.1007/0-306-46870-0_9
Sanchooli T., Norouzian M., Ardeshirylajimi A., Ghoreish, S.K., Abdollahifar M.A., Nazarian H., Piryaei A. Adipose derived stem cells conditioned media in combination with bioceramic collagen scaffolds improved calvarial bone healing in hypothyroid rats. Iran. Red. Crescent. Med. J. 2017; 19: e45516. doi: 10.5812/ircmj.45516
Song I.H., Caplan A.I., Dennis J.E. In vitro dexamethasone pretreatment enhances bone formation of human mesenchymal stem cells in vivo. J. Orthop. Res. 2009; 27: 916-921. doi: 10.1002/jor.20838
Um S., Kim H.Y., Seo B.M. Effects of BMP-2 on the osteogenic differentiation of bone marrow stem cells in fibrous dysplasia. Oral Dis. 2018; 6: 1057-1067. doi: 10.1111/odi.12869
Visser R., Rico-Llanos G.A., Pulkkinen H., Becerra J. Peptides for bone tissue engineering. J Controlled Release. 2016; 244: 122–135. doi: 10.1016/j.jconrel.2016.10.024
Yun Y.R., Jang J.H., Jeon E., Kang W., Lee S., Won J.E., Kim H.W., Wall I. Administration of growth factors for bone regeneration. Regen. Med. 2012; 7: 369-385. doi: 10.2217/rme.12.1

About Authors (Correspondence):

Sherstoboev E.Yu., e-mail: sherstoboev_eu@pharmso.ru

Full Text

snmzh_2-2020_pokrovskaya_i_dr.pdf

Received: 29/04/2020

Accepted: 29/04/2020